Pulmonary hypertension: A contraindication to the use of β-adrenoceptor blocking agents

Thorax

Volumn 65, Issue 5, 2010, Pages 454-455

  Peacock, A ^a   Ross, K ^a  

^a GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALKALINE PHOSPHATASE; AMIODARONE; BILIRUBIN; BOSENTAN; D DIMER; GAMMA GLUTAMYLTRANSFERASE; ISOPRENALINE; METOPROLOL; SILDENAFIL; WARFARIN;

ABDOMINAL DISTENSION; ADULT; ALCOHOL LIVER DISEASE; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTERIAL GAS; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIOMEGALY; CASE REPORT; CLINICAL PRACTICE; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART ARRHYTHMIA; HEART LEFT BUNDLE BRANCH BLOCK; HEART STROKE VOLUME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPOXEMIA; LIMB SWELLING; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LUNG ANGIOGRAPHY; LUNG EMBOLISM; METABOLIC ACIDOSIS; PERIORBITAL EDEMA; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RESPIRATORY ALKALOSIS; SINGLE DRUG DOSE; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; THORAX PAIN; THORAX RADIOGRAPHY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT CONTRAINDICATION; VOMITING;

EID: 77951983157     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.111955     Document Type: Article

References (10)

1. Rodriguez-Roisin R, Krowka MJ, Herve P, et al. ERS Task Force Pulmonary-Hepatic Vascular Disorders Scientific Committee. Pulmonary-hepatic vascular disorders. Eur Respir J 2004;24:861-880
2. Blei AT. Portal hypertension and its complications. Curr Opin Gastroenterol 2007;23:275-282
3. Provencher S, Herve P, Xavier J, et al. Deleterious effects of beta-blockers on exercise capacity and haemodynamics in patients with portopulmonary hypertension. Gastroenterology 2006;130:120-126 (Pubitemid 43049842)
4. Tirlapur VG, Evans PJ, Jones MK, et al. Shock syndrome after acebutolol. Br J Clin Pract 1986;40:33-34
5. Kholeif M, Isles C. Profound hypotension after atenolol in severe hypertension. BMJ 1989;298:161-162 (Pubitemid 19039678)
6. Lewis M, Kallenbach J, Germond C, et al. Survival following massive overdose of adrenergic blocking agents (acebutolol and labetalol). Eur Heart J 1983;4:328-332 (Pubitemid 13071754)
7. Lesko LJ. Pharmacokinetic drug interactions with amiodarone. Clin Pharmacokinet 1989;17:130-140
8. Fukumoto K, Kobayashi T, Tachibana K, et al. Effect of amiodarone on the serum concentration/dose ratio of metoprolol in patients with cardiac arrhythmia. Drug Metab Pharmacokinet 2006;21:501-505
9. Tongers J, Schwerdtfeger B, Klein G, et al. Incidence and clinical relevance of supraventricular tachyarrythmias in pulmonary hypertension. Am Heart J 2006;153:127-132 (Pubitemid 44889238)
10. Holdgate A, Foo A. Intervention review: adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults. Cochrane Database of Syst Rev 2006;(4):CD005154. (Pubitemid 46841139)